Selectis Health (GBCS) Cost of Revenue (2015 - 2025)

Selectis Health's Cost of Revenue history runs 11 years deep, the most recent figure standing at $7.0 million for Q4 2025.

• In Q4 2025, Cost of Revenue fell 10.99% year-over-year to $7.0 million; the TTM figure through Dec 2025 stood at $31.8 million (up 4.61% YoY), while the FY2025 annual figure was $31.8 million, up 4.61% from the prior year.
• Cost of Revenue came in at $7.0 million for Q4 2025 at Selectis Health, down from $8.5 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $8.9 million in Q4 2021 to a low of $3.5 million in Q1 2021.
• A 5-year average of $7.2 million and a median of $7.5 million in 2024 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue jumped 96.4% in 2022 and dropped 11.85% in 2024, its largest moves.
• Selectis Health's Cost of Revenue stood at $8.9 million in 2021, then declined by 2.18% to $8.7 million in 2022, then decreased by 10.66% to $7.7 million in 2023, then gained by 1.61% to $7.9 million in 2024, then declined by 10.99% to $7.0 million in 2025.
• According to Business Quant data, Cost of Revenue over the past three periods registered $7.0 million, $8.5 million, and $8.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison